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Summary. The plasma binding of prednisolone was 
studied in twenty normal volunteers and twenty 
rheumatoid arthritis patients. An in vitro assessment 
of the binding following the addition of prednisolone, 
prednisone, and hydrocorlisone to the plasmas 
obtained from the subjects showed significant differ- 
ences in the percentage of prednisolone bound. How- 
ever, the differences observed were regarded as clini- 
cally insignificant. The plasma protein binding was 
determined by an in vitro equilibrium dialysis of the 
individual plasma samples at 37°C. Prednisolone 
levels on both sides of the dialysis membrane were 
determined using radioactivity and HPLC analytical 
methodologies. The percentages of prednisolone 
bound calctflated from the analytical results of either 
the radiochemical or HPLC method were not sig- 
nificantly different. The change in the percentage of 
prednisolone bound to plasma proteins was studied 
as a function of the total prednisolone plasma con- 
centration in a normal volunteer and in a systemic 
lupus erythematosis patient. As a result of pred- 
nisolone binding to both transcortin and albumin, the 
binding of prednisolone changes as a function of 
prednisolone concentration. The binding data were 
fitted using nonlinear least squares regression, and 
the affinity constants for the binding of prednisolone 
to transcortin and albumin were estimated. 
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Prednisolone is a potent corticosteroid that is exten- 
sively used for the treatment of rheumatoid arthritis 
and various other diseases. Prednisone, on the other 
hand, is considered a pro-drug for prednisolone [1, 
2], and is employed for similar purposes as pred- 
nisolone. 
It is now recognized for many drugs [3], that the 
unbound fraction in the plasma constitutes the 
biologically active form of the drug. Thus, the deter- 
mination of the free or bound portions of various 
drugs in the plasma has important implications con- 
cerning the drug's therapeutic activity [1]. However, 
disease states may modify the protein binding of a 
particular drug [4, 5]. Hence, changes due to the dis- 
ease state may be reflected in a drug's pharmacologi- 
cal effect. 
Prednisolone has been shown to bind to both 
albumin and transcortin [4, 6-10]. To quantify the 
extent of prednisolone binding to these plasma pro- 
teins, and to determine the effect of disease state on 
the plasma protein binding, a kinetic study of the 
total plasma concentration and fraction free is neces- 
sary. 
A recent report by Rocci and Jusko [6] has shown 
that prednisolone binding to plasma proteins can be 
described by a two term function of the following 
form: 
n,K&Cf 
Cb -- + naKaPaC ~ (1) 
1 +K~C, 
where Cb and Cf are the bound and free concentra- 
tions of prednisolone, n is the number of binding sites 
per protein molecule, K is the association (binding) 
constant, and P is the protein concentration. The sub- 
scripts t and a refer to transcortin and albumin 
respectively. Thus the binding of prednisolone to 
plasma proteins is nonlinear with respect to transcor- 
tin and linear with respect to albumin. The transcor- 
tin binding sites are high affinity and low capacity 
whereas the albumin sites are low affinity but high 
capacity [5 t . 
Equation [1] can be written in the form: 
P(1)c  
C b - -  q- P(3)Cf (2)  
e(2) + Cr 
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Table 1. Albumin levels and sex of normal volunteers and arthritic 
patients 
Normal volunteers Rheumatoid arthritis patients 
Subject Sex Plasma Subject Sex Plasma Drugs a Subject 
No. albumin No. albumin No. 
g/dl g/dl 
Table 2. Percentage of prednisolone bound a to plasma proteins 
Normal volunteers Arthritic patients 
Percent bound Percent bound 
Subject 
1. run 2. run Average No. 1. run 2. run Average 
1 65.9 74.6 70.3 21 73.3 76.2 74.7 
1 M 4.3 21 F 3.2 1 2 69.5 78.3 73.9 21 70.3 70.2 70.2 
2 M 4.3 22 M 3.5 2, 3 3 68.1 76.2 72.2 23 75.6 79.7 77.7 
3 M 4.4 23 F 3.6 2, 3, 4, 5, 6 4 68.4 75.5 72.0 24 74.9 70.4 72.6 
4 F 4.2 24 M 3.7 2 5 68.2 78.4 73.3 25 75.0 74.8 74.9 
5 F 4.2 25 M 4.3 7, 8 6 69.8 71.5 70.7 26 71.8 73.9 72.9 
6 F 4.0 26 F 3.3 3, 9, 10 7 68.1 69.3 68.7 27 72.7 74.2 73.5 
7 F 3.9 27 M 3.7 2, 11 8 71.4 73.5 72.5 28 77.5 78.0 77.7 
8 M 4.2 28 F 4.2 12 9 70.5 72.4 71.5 29 73.1 73.5 73.3 
9 M 4.1 29 F 3.8 2, 7 10 68.6 69.7 69.2 30 72.1 76.4 74.3 
10 M 4.1 30 M 3.9 2, 13 I1 66.9 71.3 69.1 31 70.9 74.4 72.6 
11 M 3.9 31 F 2.9 2, 7 12 73.7 75.4 74.6 32 72.5 77.7 75.1 
12 M 4.1 32 F 3.8 2, 6, 14 13 71.1 74.1 72.6 33 76.1 76.5 76.3 
13 M 4.2 33 F 3.9 15 14 73.1 75.7 74.4 34 71.4 74.4 72.9 
14 M 4.1 34 F 3.6 2 15 72.7 76.6 74.7 35 77.6 78.7 78.1 
15 F 4.3 35 F 3.8 2 16 74.3 78.0 76.1 36 74.9 78.4 76.7 
16 F 4.1 36 F 3.9 7 17 71.6 72.9 72.2 37 76.5 78.0 77.2 
17 M 4.3 37 F 4.4 18 74.4 77.1 75.7 36 73.9 73.1 73.5 
18 M 4.5 38 F 4.1 -2, 3, 7, 11 19 b 83.2 83.1 83.1 39 73.1 73.6 73.4 
19 F 3.8 39 M 4.0 2 20 71.8 70.9 71.4 40 72.7 73.4 73.0 
20 M 4.3 40 M 3.9 2, t l  
a Drugs that the arthritic patients were taking: 1 naproxen, 2 aspi- 
rin, 3 iron, 4 propranolol, 5 isosorbide dinitrate, 6 multiple vi- 
tamins, 7 ibuprofen, 8 amitriptyline, 9 fenoprofen, 10 fotic acid, 
11 prednisone, 12 triamcinolone, 13 cimetidine, 14 vitamin C, 
15 choline salicytate 
Average: 72.4 c 74.5 c 
Variance: 4.78 4.59 
C.V. (%): 3.02 2.87 
a Determined by equilibrium dialysis and radiochemical assay of 
3H-prednisolone in plasma and buffer compartments 
b Omitted from statistical analysis (see text) 
c Difference between means is significant (t = 13.0, p<0.001) 
where P(1) = ntP t (3) 
P(2)--- 1/Kt (4) 
P(3) = naKaP a (5) 
The objective of the research reported in this 
paper was to study the plasma protein binding of 
prednisolone considering the effect of disease state 
on this process. 
Materials and Methods 
HPLC Assay and Radioactivity Assay 
The steroid concentrations of prednisolone, pred- 
nisone, and hydrocortisone were determined in 
plasma and dialysis buffer by high performance liquid 
chromatography (HPLC) (Waters Associates, Inc., 
Model 204, Nfilford, Mass.). The samples were 
extracted with methylene chloride and the extracts 
were evaporated to dryness. The dried extracts were 
reconstituted with mobile phase before injection 
onto the HPLC column. The mobile phase contained 
hexane, methylene chloride, absolute ethanol, and 
acetic acid (688 : 250: 60: 2). A ~t-Poracil column 
(Waters Associates, Inc., Milford, Mass.) 4 mm × 
30cm was used to separate the steroids. Triam- 
cinolone acetonide was used as an internal standard. 
The full details of the HPLC method will be pub- 
lished elsewhere. 
The radioactivity of the tritium labeled pred- 
nisolone was determined in plasma and dialysis buff- 
er using a scintillation counter (Packard Tri-Carb 
Liquid Scintillation Spectrophotometer, Model 3320, 
Downers Grove, Ill.). Appropriate samples of the 
plasma or buffer were transferred into 10 ml of a 
scintillation cocktail fluid (Unogel, Schwarz/Mann, 
Orangeburg, N.Y.) and counted three times for a 
period of 10 min. All counts were corrected for back- 
ground and quenching and the three results were 
averaged for each sample. The average dpm, dpm, 
were used for the percent bound calculations. 
Volunteers and Patients 
Ten ml blood samples were drawn from 20 normal, 
healthy volunteers and 20 rheumatoid arthritis 
patients. The blood samples were immediately cen- 
trifuged at 2000 rpm (Sorvall, Inc., Model RC-3 
Refrigerated Centrifuge, Newtown, Conn.) and the 
plasma samples obtained were immediately frozen at 
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Table 3. Comparison of the plasma protein binding of pred- 
nisolone as determined by radioactivity or HPLC analysis of the 
same dialysis samples 
Percent bound 
S a m p l e  Radiochemical HPLC 
No. assay assay 
average a 
N-1 b 70.3 64.5 
N-2 73.9 75.8 
N-3 72.2 69.1 
N-4 72.0 70,6 
N-5 73,3 70.9 
A-1 c 74.7 77.2 
A-2 70.2 74.8 
A-3 77.7 80.3 
A-4 72.6 7%8 
A-5 74.9 80.6 
Average: 73.2 d 74.2 d 
Variance: 5.12 e 27.4 ~ 
C.V. (%): 3.09 7.06 
a Average of two determinations 
b N refers to normal volunteers 
c A refers to arthritic patients 
d The means are not significantly different (t = 0.543, p>0.025, 
df = 13) (see ref. 18) 
e Variances are not homogeneous. (F = 5.36, p<0.05) 
Table 4. Change in the percentage of prednisolone bound to 
plasma proteins as the total concentration of prednisolone changes 
Normal R.B.a Patient W. W. b 
Prednisolone Percent Prednisolone Percent 
concentration c bound d concentration c bound d 
~M vM 
0 e 90.9 
0.0821 89.6 0.0152 84.6 
0.235 88.0 0.560 74.3 
0.344 83.2 0.444 76.3 
0.577 76.2 0.411 77.1 
0.718 67.4 0.222 82.0 
0.899 66.0 0.171 83.1 
1.19 63.0 0.108 84.6 
a Prednisolone, prednisone, and hydrocortisone (ratio 4: 1:1) 
were added to the plasma in vitro 
b Patient received a 20 mg dose of prednisone. Plasma samples 
were obtained at 0.6, 1, 2, 4, 6, and 8 hours after the dose. 
Prednisolone concentrations were determined by HPLC 
The total equilibrium concentrations (bound and free) of pred- 
nisolone 
d Determined by equilibrium dialysis with radiolabeled pred- 
nisolone 
Only radioactive prednisolone added to the sample 
- 2 0 ° C  until further use. The sex and the plasma 
albumin levels of the subjects as well as the drugs the 
arthritic patients were taking are listed in Table 1. 
The mean age of the normal group was 32 with a 
range of 24 to 49. The mean age of the arthritic 
group was 51 with a range of 21 to 72. 
Three  of the arthritic patients were receiving 
prednisone at the time of the study. For  these 
patients, the steroid levels in the plasma were first 
determined by HPLC.  The  results for the pred- 
nisolone levels were 0.0508, 0.219, and 0.299 ,uM. 
Nevertheless, during the protein binding equilibrium 
dialysis study, the same amounts of the three steroids 
were added to these samples as in all other  samples. 
For  the concentration dependent  protein binding 
study, plasma samples from a male, normal, healthy 
volunteer, R.B. ,  and a male, systemic lupus eryth- 
matosis (SLE) patient,  W. W., were used. 
Protein Binding Determination 
A freshly prepared pH 7.4 phosphate (0.0175 M) 
buffer (contained: 0.696 g dibasic potassium phos- 
phate, 0.138 g monobasic sodium phosphate, 2.25 g 
sodium chloride, p H  adjusted to 7.4, q. s. distilled 
water 500 ml) was used for all dialysis experiments 
and preparations. Cellophane dialysis tubing (Union 
Carbide, Chicago, Ill.) with a fiat diameter  of 9.5 mm 
was cut into 15 cm lengths and soaked in phosphate 
buffer for a minimum of 24 h at 4 ° C. Immediately 
before being used, the strips of dialysis tubing were 
removed f rom the soaking buffer and the excess buff- 
er was wiped away as completely as possible. 
After  tying off one end of the dialysis tubing, a 
one ml sample of plasma from an individual patient 
was placed inside the tubing from the open end. Then 
100~1 of a solution containing three unlabeled 
steroids was added to the plasma sample in the tub- 
ing. As a result of this addition, the plasma concen- 
tration inside the dialysis tubing for the three steroids 
were prednisolone, 1.09 ~tM, prednisone, 0.277 gM, 
and hydrocortisone, 0.281 gM. 
Finally, 10 ~tl of the tritium labeled prednisolone 
solution (approximately 1000 dpm/10 gl) (New Eng- 
land Nuclear, Boston, Mass.) was added to the 
plasma sample in the dialysis tubing, the end of the 
tubing was tied off, and the tubing was inverted sev- 
eral times to achieve mixing. After  being folded into 
a V shape, the dialysis tubing was placed into a 1 cm 
× 10 cm test tube containing 3 ml of the phosphate 
buffer. The top of the tube was sealed with parafilm 
to prevent loss by evaporation and the outside of the 
test tube was covered with aluminum foil to minimize 
light exposure. 
The prepared dialysis test tubes were oscillated in 
a 37°C water bath (Lab-Line Instruments, Inc., 
Model  3581, Melrose Park, Ill.) for 16h.  After  
removal from the water bath, the dialysis tubing was 
removed from the buffer and the outside of the dialy- 
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PLASMA CONCENTRATION OF FREE (UNBOUND) PREDNISOLONE (#M) 
Fig, 1. Plot of Bound versus Free Concentrations of 
Prednisotone in Plasma. Key: • normal male vol- 
unteer R. B.: lk SLE patient W. W.: <> Point is for 
the 19 normals. (These plasmas initially contained 
1.09 glVI prednisolone. The total equilibrium con- 
centration was 0.597 gM. The average percent 
bound by the 19 normals was 72.4%). The points 
plotted are the observed free and bound equilib- 
rium concentrations, l~e lines are the estimated 
values based on Eq. I and the least square estimates 
of the parameters in Table 5 
Table 5. Least squares estimates of parameters based on the fitting of prednisolone plasma protein binding data 
Plasmas Parameters a Measures Calculated 
utilized of fit parameters 
e(1) e(2) e(3) r 2b corr. c tG a (M-l) a K, (M-1) 
Normal 0.293 0.0180 1.05 0.998 0.995 1.8 X 10 3 5.6 × 107 
(0.0314) e (0.00445) (0.091) 
Patient 0.235 0.0414 1.62 1.000 1.000 2.7 X 10 3 2.4 × 107 
(0.00585) (0.00086) (0.0324) 
a Least square estimates of the parameters of Eq. (2) when C b and Cf were in ~*M units 
b Coefficient of determination 
c Correlation coefficient for the linear regression of estimated bound concentration versus observed bound concentration of prednisolone 
a Assuming na = I for albumin, an albumin molecular weight of 66.500 (ref. 15), and albumin concentrations for normal (3.9 g/dl) and 
patient (4.0 g/dl) 
Standard deviation of the estimated parameters 
T w o  0.5 mt  samples  were  ob ta ined  f r o m  the  con-  
tents  of  the irtside of  the dialysis tubing and  two 
1.0 ml samples were  ob ta ined  f rom the dialysis buffer  
(outside).  A f t e r  analysis by  radiochemical  assay (or  
H P L C )  of  each of  the samples,  the  pe rcen tage  of  
p redniso tone  b o u n d  to  the  p lasma  prote ins  was cal- 
cula ted  using the  fol lowing equat ion:  
pe rcen t  b o u n d  = (dpm)i " 2 - (dpm)o . 100 (6) 
(dpm) i .  2 
where  the subscripts i and  o refer  to  inside and out -  
side samples,  respectively.  F o r  H P L C  analysis, the  
a m o u n t  of  p redniso lone  in the sample  was used for  
the above  calculat ion ins tead of  the dpm.  T h e  I-IPLC 
analysis was only  conduc ted  on  the  samples f r o m  the 
first 5 subjects  of  bo th  groups.  O n c e  equivalence  of  
the  two m e t h o d s  of  assay was established only the  
radiochemical  assay was used thereafter .  
Protein Binding Versus Concentration 
T he  endogenous  hydrocor t i sone  of  the  normal  volun-  
teer,  R . B . ,  was suppressed by the adminis t ra t ion o f  
I m g  of  dexame thasone  9 h pr ior  to  b lood  collection. 
T h e  b lood  sample  was d rawn and  the p lasma was 
separa ted  by  centr ifugation.  Since the dcx-  
ame thasone  p lasma concent ra t ion  9 h after  adminis-  
t ra t ion would  be  exceedingly small, we cons idered  
the dexame thasone  interference with predniso lone  
binding to  be  minimal.  Dif ferent  but  k n o w n  volumes  
o f  a s teroid solut ion which conta ined  prednisolone,  
prednisone,  and  hydrocor t i sone  in the  rat io of  4 :  1 : 1 
were  added  to 1.0 ml aliquots of  the normal ' s  plasma.  
T h e  S L E  patient,  W.  W., who  was receiving pred-  
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nisone regularly, was given a 20 mg dose of pred- 
nisone at 8 a.m. Blood samples from the patient 
were taken at 0.6, 1, 2, 4, 6, and 8 h after the dose. 
The total prednisolone concentration of the plasma 
was determined for each of the timed samples by 
I-IPLC analysis. 
The plasma samples from the patient and normal 
volunteer were used to evaluate the concentration 
dependent plasma protein binding of prednisolone. 
The procedure described above for protein binding 
was used for this evaluation except that no additional 
unlabelled steroids were added to the samples. 
Results 
Comparison of  Prednisolone Protein Binding 
in Normals and Arthritics 
The percentage of prednisolone bound to the plasma 
protein for each of the 20 normals and arthritics is 
given in Table 2 as determined by equilibrium dialy- 
sis and radiochemical analysis of the plasma and 
buffer compartments for 3H-prednisolone. 
The data for subject 19 were omitted from the 
parametric statistical analysis because the results 
from this subject differ by more than 4 standard devi- 
ations from the mean of the other normals and by 
more than 3 standard deviations from the next high- 
est average observation of the normal group. 
The variances of the two groups, normals and 
arthritics, were compared using an F test and were 
found not significantly different (F = 1.04 p>0.25). 
A Student t-test for differences between the means 
was significant. The statistical tests are summarized 
in Table 2. Additionally, the data for all 20 normal 
volunteers versus the 20 arthritic patients were com- 
pared using a nonparametric Mann-Whitney test and 
the two groups were shown to differ significantly (u 
= 106, p<0.01) in the percentages of prednisolone 
bound. However, the differences observed are 
regarded as clinically insignificant. 
Comparison of  Radioactivity Versus HPLC Methods 
The equilibrium dialysis samples from the first 5 nor- 
reals and arthritic subjects were measured both by 
radioactivity counting of the 3H-prednisolone and by 
HPLC quantification of the total amount of pred- 
nisolone in the samples. These measurements were 
used to calculate the percentage of prednisolone 
bound to the plasma proteins. The results from these 
two methods are presented in Table 3. The same 
dialysis test tube was sampled by both methods. 
The variances of the two sets of data are not 
homogeneous by an F test. A paired Student t-test, 
corrected for unequal variances [18], was used to test 
the difference between the two methods and the dif- 
ference between the mean percentages bound was 
found to be not significant. The statistical tests are 
summarized in Table 3. 
Change in the Percentage of  Prednisolone Bound 
to ProWin Versus the Concentration of  Prednisolone 
The percentage of prednisolone bound to the plasma 
proteins changes as a function of the total concentra- 
tion of prednisolone in the plasma due to the non- 
linear protein binding of prednisolone as described 
by Eq. (1). Table 4 shows the change in the percent 
bound for the normal volunteer and the SLE patient 
where the plasma protein binding of prednisolone 
was studied at different total concentrations of pred- 
nisolone. 
A protein binding plot of the concentration 
bound versus concentration free of prednisolone is 
shown for these subjects in Figure 1. The concentra- 
tions plotted on Figure t are the bound and free 
equilibrium concentrations. Also shown in Figure i is 
a single point representing the average of the con- 
centration bound versus concentration free for the 19 
normal subjects. 
After obtaining the initial estimates of the para- 
meters of Eq. (2) by manual stripping techniques, the 
data from the normal and SLE patient were fit to Eq. 
(3) using a digital computer and the program NON- 
LIN (11). During this fitting, the concentrations were 
weighted as their recriprocals. The least square esti- 
mates of these parameters, the measures of fit, and 
some calculated parameters for the protein binding 
of prednisolone are shown in Table 5. 
Discussion 
The in vitro study of the 20 normals and 20 
rheumatoid arthritis patients showed a significant dif- 
ference in the percentage of prednisolone bound to 
the plasma proteins. However, at the level of binding 
observed, the differences between the two groups are 
not clinically significant as the fraction free would not 
be dramatically changed due to the additional mean 
binding of the arthritic group. 
The results of this study must be viewed with cau- 
tion. It must be emphasized that three steroids, pred- 
nisolone, prednisone, and hydrocortisone, were 
added to these plasmas. These steroids are all known 
to bind to albumin and transcortin [7]. Thus, the 
binding of each individual steroid will influence the 
binding of the others by competition for the same 
binding sites. Furthermore, the exact concentration 
ratio of the three steroids employed in these studies 
may not equate to clinically observed steroid con- 
centrations. However, previous studies done in this 
laboratory [12] have shown the peak plasma concen- 
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tration of prednisolone to be approximately three 
times the prednisone concentrations. A similar ratio 
was used for the present study. 
The difference between the albumin levels of the 
two groups should also be noted. The normal group 
had a significantly higher albumin level than the ar- 
thritic group (t = 4.31, p<0.001). However, besides 
the disease state, the mean age of the two groups was 
dissimilar. Plasma albumin levels are known to 
decrease with age [13] and in inflammatory disease 
[5, 14]. In addition, however, the structure of the 
protein may be different due to the disease state [16, 
17]. In spite of the lower albumin levels in the ar- 
thritic group, the observed trend of the plasma pro- 
tein binding of prednisolone was toward a greater 
percentage bound in the arthritic group. This trend is 
opposite to that which is expected based upon the 
change in albumin concentration alone. Thus, there 
may" be a duplicity of effects resulting from the lower 
albumin levels occurring in conjunction with an 
altered albumin molecule which causes different 
affinities of the protein for prednisolone. 
The results obtained by radiochemical or HPLC 
analytical methods in the determination of protein 
binding of prednisolone were not significantly differ- 
ent as shown in Table 3. The variance was greater for 
the HPLC method. However, this result was 
expected as the prednisolone concentrations in the 
dialysis buffer were near the limits of detection for 
the HPLC analysis. The agreement of the two analyt- 
ical methods indicates that the radiochemical method 
is adequate. Because of the greater variance associ- 
ated with the HPLC analysis method, the radiochem- 
ical method of determination is preferred. 
The fitting of the normal volunteer's and SLE 
patient's concentration bound versus concentration 
free data shows the nonlinearity of the plasma pro- 
tein binding of prednisolone. The affinity constants 
derived for albumin and transcortin are in agreement 
with other investigators [6]. These data confirm the 
high affinity and low capacity of prednisolone bind- 
ing to transcortin and the low affinity but high capac- 
ity of albumin binding. 
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